Infectious Diseases News and Research

RSS

Unique pain program helps surgical patients wean off opioids safely and effectively

A unique pain program is helping complex surgical patients wean off opioids safely and effectively, while offering alternative ways to cope with their pain and improve how they function.

20 Aug 2018

New modeling studies highlight urgent need for effective drug policy reforms to prevent HIV

While global incidence rates of HIV have declined notably in recent years, the virus that causes AIDS remains a major and, in some ways largely unmitigated, public health threat in some countries and regions.

17 Aug 2018

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

Ology Bioservices, Inc., a biologics contract development and manufacturing organization, announced today that it was awarded an Other Transaction Agreement to support the Joint Project Manager Medical Countermeasure Systems, a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense for advanced biologics manufacturing services—specifically, to manufacture an anti-Ebola monoclonal antibody.

17 Aug 2018

NIH begins first-in-human trial of experimental live, attenuated Zika virus vaccine

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

16 Aug 2018

Mathematical model shows the influence of human behavior on spread of infectious diseases

Mathematics can help public health workers better understand and influence human behaviors that lead to the spread of infectious disease, according to a study from the University of Waterloo.

16 Aug 2018

New polyclonal immunotherapy successfully neutralizes Ebola virus

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided "100% protection against a lethal dose of the Ebola virus" in a recent animal study published in The Journal of Infectious Diseases.

15 Aug 2018

Simple intervention during routine care reduces alcohol consumption in men with HIV

Among the more than 1 million people in the U.S. living with HIV, 19 percent meet the criteria for an alcohol use disorder.

14 Aug 2018

Study: IgG3 antibody stops B cells from fighting pathogens in HIV patients

For the first time, scientists have shown that in certain people living with HIV, a type of antibody called immunoglobulin G3 stops the immune system's B cells from doing their normal job of fighting pathogens.

14 Aug 2018

Study may help increase effectiveness of antibiotics against drug-resistant bacteria

Bacteria - especially Gram-negative strains - are becoming increasingly resistant to current antibiotic drugs, and the development of new classes of antibiotics has slowed.

13 Aug 2018

Experts highlight key knowledge gaps that need to be addressed in Ebola vaccine research

Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine, according to members of an international Ebola research consortium.

13 Aug 2018

Genetic sequencing method identifies pathogens behind respiratory illnesses in Uganda

A study led by researchers at Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the use of a genetic sequencing method to identify viral pathogens behind unexplained respiratory illnesses in Uganda over a five-year period.

10 Aug 2018

Obesity in PTSD patients accounts for increased risk of type 2 diabetes mellitus

Saint Louis University research finds post-traumatic stress disorder does not directly lead to type 2 diabetes mellitus, instead obesity in PTSD patients accounts for the increased risk.

10 Aug 2018

Collaboration between Merck and InnoCore could improve biologic drug delivery

Following today’s (Friday 3 August) announcement of Merck and InnoCore’s collaboration, Rahael Maladwala, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on what this might mean for biologic drug delivery:

10 Aug 2018

One-two punch of powerful antibodies may be best way to stop Ebola virus

A one-two punch of powerful antibodies may be the best way to stop Ebola virus, reports an international team of scientists in the journal Cell.

10 Aug 2018

New method evaluates effectiveness of interventions in mitigating spread of HIV

Using genetic sequencing to understand the evolutionary relationships among pathogens, an international team of researchers - including several from the Center for Drug Use and HIV/HCV Research at New York University - has developed a new method to determine how effective interventions are against the spread of infectious diseases like HIV.

9 Aug 2018

Infectious Diseases News and Research

Unique pain program helps surgical patients wean off opioids safely and effectively

New modeling studies highlight urgent need for effective drug policy reforms to prevent HIV

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

NIH begins first-in-human trial of experimental live, attenuated Zika virus vaccine

Mathematical model shows the influence of human behavior on spread of infectious diseases

New polyclonal immunotherapy successfully neutralizes Ebola virus

Simple intervention during routine care reduces alcohol consumption in men with HIV

Study: IgG3 antibody stops B cells from fighting pathogens in HIV patients

Study may help increase effectiveness of antibiotics against drug-resistant bacteria

Experts highlight key knowledge gaps that need to be addressed in Ebola vaccine research

Genetic sequencing method identifies pathogens behind respiratory illnesses in Uganda

Obesity in PTSD patients accounts for increased risk of type 2 diabetes mellitus

Collaboration between Merck and InnoCore could improve biologic drug delivery

One-two punch of powerful antibodies may be best way to stop Ebola virus

New method evaluates effectiveness of interventions in mitigating spread of HIV

Study reveals cellular pathway used by Ebola virus to enter cells

Mandatory vaccinations for children stopped in Italy

Study highlights impact of silent viruses on how the host responds to vaccines

EMA grants orphan designation to selumetinib for treatment of neurofibromatosis type 1

Obesity increases viral shedding duration in adults with influenza A

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News